Company Monitoring Page for Biogen

latest headlines for company on cafepharma

FDA, in another test of its flexibility, agrees to review Biogen’s closely watched ALS drug
BioPharma Dive
Tue, 07/26/22 - 11:08 am
Tags:
Biogen, ALS, tofersen, FDA
Novartis asks FDA to approve biosimilar for Biogen’s top-selling MS drug
BioPharma Dive
Mon, 07/25/22 - 09:54 pm
Tags:
Novartis, FDA, Biogen, biosimilars, Tysabri, MS, multiple sclerosis
Roche, Biogen temper Alzheimer’s expectations in Q2 calls. Will Lilly follow suit in August?
Fierce Biotech
Fri, 07/22/22 - 11:21 am
Tags:
Alzheimer's disease, Roche, Biogen, Eli Lilly, lecanemab, gantenerumab, Aduhelm
For accounting purposes, Biogen says its $223M inventory of Aduhelm is basically worthless
Endpoints
Thu, 07/21/22 - 09:47 pm
Tags:
Biogen, Aduhelm, Alzheimer's disease, SEC
Biogen pays $900M to resolve whistleblower's MS kickback suit as competition drags on sales
Fierce Pharma
Wed, 07/20/22 - 11:17 pm
Tags:
Biogen, whistleblowers, multiple sclerosis, MS, kickbacks
Biogen posts solid quarter but pipeline slims ahead of key data for its second controversial Alzheimer's drug
Endpoints
Wed, 07/20/22 - 09:43 am
Tags:
Biogen, earnings
Biogen, targeting $1B in savings, employs 300 fewer staffers in Massachusetts than it did in September: report
Fierce Biotech
Mon, 07/18/22 - 07:19 pm
Tags:
Biogen, layoffs, Cambridge MA, Aduhelm
Biogen gains prominent ally in bid for Supreme Court to review Tecfidera patent case
Fierce Pharma
Wed, 07/13/22 - 08:17 pm
Tags:
Biogen, Tecfidera, patents, Supreme Court
Biogen-Eisai go for another biomarker approval in Alzheimer's with lecanemab—and snag priority review
Fierce Biotech
Tue, 07/5/22 - 11:58 pm
Tags:
Biogen, Eisai, FDA, biomarkers, Alzheimer's disease, lecanemab
Biogen, citing insurance challenges, shutters one of its Aduhelm studies
BioPharma Dive
Wed, 06/22/22 - 06:54 pm
Tags:
Biogen, real world data, Alzheimer's disease, Medicare, Aduhelm
Biogen Halts ALS Asset Agreement with Karyopharm
BioSpace
Thu, 06/16/22 - 10:25 am
Tags:
Biogen, Karyopharm Therapeutics, ALS, KPT-350
Biogen bolsters pipeline again with Alectos deal
Pharmaforum
Tue, 06/7/22 - 09:56 am
Tags:
Biogen, Parkinson's Disease, Alectos, AL01811
After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect
Fierce Biotech
Fri, 06/3/22 - 09:16 am
Tags:
Biogen, Ionis Pharmaceuticals, ALS, clinical trials, antisense, SOD1-ALS
Biogen, Samsung Bioepis launch ranibizumab-nuna in US
Ophthalmology Today
Fri, 06/3/22 - 09:11 am
Tags:
Biogen, Samsung Bioepis, ranibizumab, ranibizumab-nuna, biosimilars, Roche, Lucentis, retinal disease
Sage, Biogen drug meets goal in postpartum depression study
BioPharma Dive
Wed, 06/1/22 - 07:32 pm
Tags:
SAGE Therapeutics, Biogen, FDA, zuranolone, postpartum depression
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
BioPharma Dive
Tue, 05/31/22 - 11:56 pm
Tags:
Medicare, Medicare Part B, Biogen, Aduhelm, HHS, Alzheimer's disease
Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision
Biopharma Reporter
Mon, 05/16/22 - 10:48 am
Tags:
Biogen, Aduhelm, monoclonal antibodies, CMS, Alzheimer's disease, neurologists
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Tags:
Pfizer, Biohaven, licensing, M&A, Aurinia, Bristol Myers Squibb, AbbVie, Alector, Arcus Biosciences, Biogen, Blueprint Medicines, CureVac, Gilead Sciences, GSK, Incyte, MorphoSys, Roche, Nestle, SAGE Therapeutics, Sarepta Therapeutics, Seres Therapeutics, Syndax
Biogen taps digital therapeutics biotech for music-based therapy to help people with MS improve their walking
Endpoints
Sun, 05/8/22 - 12:10 pm
Tags:
Biogen, digital healthcare, digital therapeutics, MedRhythms, MS, multiple sclerosis
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Tags:
Biogen, earnings, SEC, Eli Lilly, Merck, Bristol Myers Squibb, Pfizer, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.